Indian Patent office issues new guidelines for pharmaceutical patent applications
Generic disclosure in the prior art may not necessarily take away the novelty of a specific disclosureTaking into account the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
World Ayurveda Congress aims to boost traditional Indian healing systems
200 practitioners to attend Nov 6-7 healers meet
The 6th World Ayurveda Congress (WAC) starting this week in the national…
Lupin gets US FDA approval for generic Celebrex capsules
Lupin's Celecoxib capsules are the AB-rated generic equivalents of GD Searle LLC 's Celebrex capsules
Lupin has received final…
Celanese discusses innovative uses for EVA polymers at AAPS, San Diego
EVA applications expanded into oral dosageCelanese Corporation, a global technology and speciality materials company, will be…
Suven begins phase I trial of NCE SUVN-G3031 in US
SUVN-G3031 is for cognition in alzheimer’s disease under US-IND 123179
Suven Life Sciences informed that their NCE SUVN-3031 has…
Lilly shares insights from decade-long technology transfer experience
New white paper documents Lilly’s philanthropic efforts
Eli Lilly and Company (NYSE: LLY) recently published details of its…
Steered by HLL, GAPL expands operations in Goa
First GAPL Medicentre public pharmacy outlet inaugurated in Panaji
Indian Patent office issues new guidelines for pharmaceutical patent applications
Generic disclosure in the prior art may not necessarily take away the novelty of a specific disclosure Taking into account the…
World Ayurveda Congress aims to boost traditional Indian healing systems
200 practitioners to attend Nov 6-7 healers meet
Lupin gets US FDA approval for generic Celebrex capsules
Lupin's Celecoxib capsules are the AB-rated generic equivalents of GD Searle LLC 's Celebrex capsules